Products - Genomic biomarker-based cancer treatments | Topic | NICE

Showing 2 products

Date | Title

Status: PublishedRemove ‘Status: Published’ filter

Entrectinib for treating NTRK fusion-positive solid tumours (TA644)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
12 August 2020
Larotrectinib for treating NTRK fusion-positive solid tumours (TA630)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 May 2020